147 related articles for article (PubMed ID: 35438397)
1. Factors predicting the treatment frequency of ranibizumab injections during the second year in diabetic macular edema.
Nishikawa K; Murakami T; Ishihara K; Dodo Y; Terada N; Morino K; Tsujikawa A
Jpn J Ophthalmol; 2022 May; 66(3):296-304. PubMed ID: 35438397
[TBL] [Abstract][Full Text] [Related]
2. Association between characteristics of foveal cystoid spaces and short-term responsiveness to ranibizumab for diabetic macular edema.
Murakami T; Suzuma K; Uji A; Yoshitake S; Dodo Y; Fujimoto M; Yoshitake T; Miwa Y; Yoshimura N
Jpn J Ophthalmol; 2018 May; 62(3):292-301. PubMed ID: 29460019
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography biomarkers DROL, PROS, SND, hyperreflective walls of foveal cystoid spaces as predictors of central macular thickness and visual acuity in diabetic macular edema treated with intravitreal ranibizumab.
Sardana A; Singh K; Singh A; Singh VK
Indian J Ophthalmol; 2024 May; 72(5):722-727. PubMed ID: 38648434
[TBL] [Abstract][Full Text] [Related]
4. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema.
Mori Y; Murakami T; Suzuma K; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Tsujikawa A
PLoS One; 2017; 12(4):e0175809. PubMed ID: 28407012
[TBL] [Abstract][Full Text] [Related]
5. Predictors of As-Needed Ranibizumab Injection Frequency in Patients With Macular Edema Following Retinal Vein Occlusion.
Yiu G; Huang D; Wang Y; Wang Z; Yang M; Haskova Z
Am J Ophthalmol; 2023 May; 249():74-81. PubMed ID: 36646240
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal Ranibizumab and Dexamethasone Implant Injections as Primary Treatment of Diabetic Macular Edema: The Month 24 Results from Simultaneously Double Protocol.
Kaya M; Atas F; Kocak N; Ozturk T; Ayhan Z; Kaynak S
Curr Eye Res; 2023 May; 48(5):498-505. PubMed ID: 36629472
[TBL] [Abstract][Full Text] [Related]
7. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
[TBL] [Abstract][Full Text] [Related]
8. Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.
Karst SG; Lammer J; Mitsch C; Schober M; Mehta J; Scholda C; Kundi M; Kriechbaum K; Schmidt-Erfurth U
Graefes Arch Clin Exp Ophthalmol; 2018 Jan; 256(1):49-58. PubMed ID: 29080915
[TBL] [Abstract][Full Text] [Related]
9. Hyperreflective Walls in Foveal Cystoid Spaces as a Biomarker of Diabetic Macular Edema Refractory to Anti-VEGF Treatment.
Terada N; Murakami T; Uji A; Dodo Y; Mori Y; Tsujikawa A
Sci Rep; 2020 Apr; 10(1):7299. PubMed ID: 32350366
[TBL] [Abstract][Full Text] [Related]
10. Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).
Ehrlich R; Pokroy R; Segal O; Goldstein M; Pollack A; Hanhart J; Barak Y; Kehat R; Shulman S; Vidne O; Abu Ahmad W; Chowers I
Eur J Ophthalmol; 2019 Mar; 29(2):229-233. PubMed ID: 29916263
[TBL] [Abstract][Full Text] [Related]
11. Association between the patterns of diabetic macular edema and photoreceptors' response after intravitreal ranibizumab treatment: a spectral-domain optical coherence tomography study.
Chatziralli I; Theodossiadis G; Dimitriou E; Kazantzis D; Theodossiadis P
Int Ophthalmol; 2020 Oct; 40(10):2441-2448. PubMed ID: 32424527
[TBL] [Abstract][Full Text] [Related]
12. Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.
Patrao NV; Antao S; Egan C; Omar A; Hamilton R; Hykin PG; Sivaprasad S; Rajendram R;
Am J Ophthalmol; 2016 Dec; 172():51-57. PubMed ID: 27637784
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of retinal inflammatory biomarkers after intravitreal steroid implant and Ranibizumab injection in diabetic macular edema.
Muftuoglu IK; Tokuc EO; Sümer F; Karabas VL
Eur J Ophthalmol; 2022 May; 32(3):1627-1635. PubMed ID: 34219488
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
[TBL] [Abstract][Full Text] [Related]
15. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial.
Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R
Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786
[TBL] [Abstract][Full Text] [Related]
17. Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab.
Yoshitake T; Murakami T; Suzuma K; Fujimoto M; Dodo Y; Tsujikawa A
Sci Rep; 2019 May; 9(1):7599. PubMed ID: 31110273
[TBL] [Abstract][Full Text] [Related]
18. Hyperreflective Foci in the Outer Retinal Layers as a Predictor of the Functional Efficacy of Ranibizumab for Diabetic Macular Edema.
Yoshitake T; Murakami T; Suzuma K; Dodo Y; Fujimoto M; Tsujikawa A
Sci Rep; 2020 Jan; 10(1):873. PubMed ID: 31964970
[TBL] [Abstract][Full Text] [Related]
19. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal Ranibizumab Alone or in Combination with Calcium Dobesilate for the Treatment of Diabetic Macular Edema in Nonproliferative Diabetic Retinopathy Patients: 12-Month Outcomes of a Retrospective Study.
Wang D; Wang H; Wu S; Yang X; Xu J
Int J Clin Pract; 2022; 2022():6725225. PubMed ID: 36340967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
